DEF 14A

Company

TEVA PHARMACEUTICAL INDUSTRIES LTD

Filed

April 21, 2021

Period of Report

June 14, 2021

Accession Number

0001193125-21-124697

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →